Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOICES: XR-NTX for HIV-Infected Opioid and Alcohol Users
NCT01908062Phase 3Completed
- Sponsor
- Oregon Health & Science University
- Start
- Jun 2014
- Primary completion
- Mar 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of naltrexone in opioid use disorder (OUD), alcohol use disorder (AUD), sponsored by Oregon Health & Science University. Started Jun 2014; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT01908062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01908062.